Polaryx Therapeutics, Inc.
View this filing on EDGAR (filing index, accession 0001213900-25-084152) | All Form C filings by this company on EDGAR
Filing details
| Company | Polaryx Therapeutics, Inc. | (Form C, issuer information) |
|---|---|---|
| State | NJ | (Form C, issuer information) |
| Platform | DEALMAKER SECURITIES LLC | (Form C, issuer information) |
| Filing date | 2025-09-03 | (EDGAR filing index) |
| Date of incorporation | 2014-08-22 | (Form C, issuer information) |
| Employees | 11 | (Form C, issuer information) |
| Security offered | Common Stock | (Form C, offering information) |
| Price per security | $1 | (Form C, offering information) |
| Target amount | $15,000 | (Form C, offering information) |
| Maximum ask | $5,000,000 | (Form C, offering information) |
| Offering deadline | 2026-03-31 | (Form C, offering information) |
| Platform compensation | DealMaker will receive an 8.5% cash commission on securities sold in the offering (inclusive of all payment processing, transaction, e-signature and AML fees). There is also a $2,000 monthly platform fee and a $16,500 setup fee payable to DealMaker. | (Form C, offering information) |
Financial summary
Figures are as entered by the company in the financial summary on the cover of its Form C. They are self-reported and unaudited, and they are not taken from the financial statements filed as exhibits to the Form C, which we do not read mechanically.
| Item | Most recent fiscal year | Prior fiscal year | Source |
|---|---|---|---|
| Revenue | $0 | $0 | (Form C, financial summary) |
| Cost of goods sold | $0 | $0 | (Form C, financial summary) |
| Net income | -$30,356,000 | -$3,779,000 | (Form C, financial summary) |
| Taxes paid | $0 | $0 | (Form C, financial summary) |
| Cash and equivalents | $4,621,000 | $2,000 | (Form C, financial summary) |
| Accounts receivable | $0 | $0 | (Form C, financial summary) |
| Total assets | $5,001,000 | $2,315,000 | (Form C, financial summary) |
| Short-term debt | $0 | $128,000 | (Form C, financial summary) |
| Long-term debt | $0 | $0 | (Form C, financial summary) |
Mechanical checks that fired
- Going-concern language. Going-concern language appears in this offering's own Form C filing or in an amendment to it, in a sentence that states it rather than ruling it out. The quoted sentence is below. Read the auditor or accountant notes in the filing for the full context. Found in: 0001213900-25-084152, 0001213900-25-094743.
"Liquidity and Going Concern The Company has no products approved for sale and has sustained recurring net losses and negative cash flows from operations since inception."
"Liquidity and Going Concern The Company has no products approved for sale and has sustained recurring net losses and negative cash flows from operations since inception."
- Related-party language. Related-party language appears in this offering's own Form C filing or in an amendment to it, in a sentence that states it rather than ruling it out. The phrase can describe routine or unusual arrangements, so read the quoted sentence and the filing. Found in: 0001213900-25-084152, 0001213900-25-094743.
"See “Related Party Transactions - Mstone Partners Healthcare Limited”."
"See “Related Party Transactions - Mstone Partners Healthcare Limited”."
- Net loss in both years. Net income is negative in both fiscal years reported in the Form C financial summary.
- Cash below one year of losses. Net loss for the most recent fiscal year is larger than year-end cash, both as reported in the Form C financial summary.
- No revenue. Revenue for the most recent fiscal year is $0 in the Form C financial summary.
- Maximum ask above 10x revenue. The maximum offering amount is more than 10 times the most recent fiscal year revenue (or revenue is $0), per the Form C.
- Platform compensation of 8% or more. The platform compensation stated in the Form C is 8% or more of the offering.
A check means "read this part of the filing closely." It is not a judgment about how the company will do.
Want the weekly briefing? Subscribe free.